[{"uuid": "0ce396f4-9087-3aac-9c82-b4a530211fe0", "title": "Why Is Andreas Halvorsen Bullish On Edgewise Therapeutics, Inc. (EWTX) Now?", "publisher": "Insider Monkey", "link": "https://finance.yahoo.com/news/why-andreas-halvorsen-bullish-edgewise-063722194.html", "providerPublishTime": 1737614242, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/nnZy9HsCfmFJiRZN4Ysh6w--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4ebda038cc9313d4d6143077826a5884", "width": 1456, "height": 816, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/3f3mlSTW0Z0VLgrrfBRBlQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4ebda038cc9313d4d6143077826a5884", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "950facd4-4bc1-316a-aa66-61fadf8e59cf", "title": "Edgewise Therapeutics Names Behrad Derakhshan as COO; Shares Fall", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-names-behrad-derakhshan-145205466.html", "providerPublishTime": 1737557525, "type": "STORY", "relatedTickers": ["EWTX"]}, {"uuid": "7c37cf8e-f8bb-377f-aaac-48d84662abc1", "title": "Stifel Nicolaus Initiates Coverage on Edgewise Therapeutics With Hold Rating, $30 Price Target", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/stifel-nicolaus-initiates-coverage-edgewise-124259978.html", "providerPublishTime": 1737549779, "type": "STORY", "relatedTickers": ["EWTX"]}, {"uuid": "f077f42d-02e0-3286-a186-b52908188c4c", "title": "Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-strengthens-leadership-team-130000664.html", "providerPublishTime": 1737550800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/xnj5hHFwFXSTbptSMvCiDg--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f4737727007e5df84f6544bc864b47be", "width": 480, "height": 480, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/A9.66TOGdSYYFCE6X046Pw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f4737727007e5df84f6544bc864b47be", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "50d30129-00a3-3ec5-a228-2907895e1375", "title": "Edgewise Therapeutics (NASDAQ:EWTX) Is In A Good Position To Deliver On Growth Plans", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-nasdaq-ewtx-good-141912331.html", "providerPublishTime": 1737123552, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TLyt5D16lsSwRjJRVjlUTA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/z2gq8yB1R5a4THvSEUeVaQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "7ed012c5-c866-3146-9f2c-2799d5444035", "title": "Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-provides-corporate-highlights-130000128.html", "providerPublishTime": 1736773200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/ybRR0G_8xwGn2vGdnG8j1w--~B/aD0xODA4O3c9ODMzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/3a0a82ad5ec6b93201de1218e7470128", "width": 8334, "height": 1808, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/XWB9kYmSEMlAnfZDQ31_Fg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/3a0a82ad5ec6b93201de1218e7470128", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "2b02ebd6-355a-3cc4-a704-5eff6afcd37c", "title": "Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biotech-stock-roundup-nmra-plunges-184800572.html", "providerPublishTime": 1736448480, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.WQmSb1MJO1_eLnmBVS1zA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/pa5q6Axi5bBp9pCuwXBcUg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["HOTH", "NMRA", "TEVA"]}, {"uuid": "8adbc2c7-eca0-3f6b-9cbf-bb5482e6a30e", "title": "Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-present-43rd-annual-130000913.html", "providerPublishTime": 1736254800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/F_z.a1F7g4cMu6JCThl9kQ--~B/aD0xODA4O3c9ODMzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/fd0c0e2cf8b5fb52fa0a50ccdfb9495e", "width": 8334, "height": 1808, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/daTpJndTbcjKiZ83Foz6.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/fd0c0e2cf8b5fb52fa0a50ccdfb9495e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "b219c62b-fbcc-3d28-9022-5c74e3b2b97f", "title": "EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/ewtx-stock-rises-upbeat-data-141800266.html", "providerPublishTime": 1734445080, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/IYksUEF.ZX5JOPFmQ194jQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX", "SPRO"]}, {"uuid": "9e77af5c-1228-37ac-b62f-8e5a5999329a", "title": "Edgewise Therapeutics Insider Sold Shares Worth $2,737,470, According to a Recent SEC Filing", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-insider-sold-shares-221620701.html", "providerPublishTime": 1735683380, "type": "STORY", "relatedTickers": ["EWTX"]}, {"uuid": "be3eefcd-1dd5-3f13-b14f-efd6052cbde3", "title": "Edgewise's Phase 2 Trial of Sevasemten to Treat Becker Muscular Dystrophy Meets Primary Endpoint; Shares Up 22% Pre-Bell", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/edgewise-apos-phase-2-trial-125529022.html", "providerPublishTime": 1734353729, "type": "STORY", "relatedTickers": ["EWTX"]}, {"uuid": "1475cfe7-9f69-32e5-9d97-68cd8e9cfad3", "title": "Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease", "publisher": "Benzinga", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-lead-candidate-reduces-165624618.html", "providerPublishTime": 1734368184, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/JtMJqqV01ML0g6i4.TdV2g--~B/aD01Mzg7dz05NTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/146a4ab97e806d7f24cf345f0de503c4", "width": 956, "height": 538, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/uCz_7bf6IxIZclI2_pDipA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/146a4ab97e806d7f24cf345f0de503c4", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "854e155b-3c23-3e9f-93ee-e63263000663", "title": "Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-announces-positive-topline-110000783.html", "providerPublishTime": 1734346800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/Z2XGi56jMUU8w6CdgshRAg--~B/aD0xODA4O3c9ODMzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/2f8c1ba17afa6f9037bf4600c19db1a8", "width": 8334, "height": 1808, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/qZgvZQsV3SFi8SKNaaNgzw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2f8c1ba17afa6f9037bf4600c19db1a8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "5d82bfa0-86ab-38c0-9448-42ce34f3c801", "title": "Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/biotech-stock-roundup-updates-gild-142300473.html", "providerPublishTime": 1734531780, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QieiOVP5CdM1cfxTnlcVfQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795", "width": 620, "height": 413, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/1hcqAcr._xcksqqDo_WNwA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["GILD", "REGN", "EWTX"]}, {"uuid": "2239155d-377d-3dc0-b558-e5d80d9ff3f0", "title": "Edgewise Therapeutics Clarifies FDA Warning Unrelated to Clinical Trials, Data", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/edgewise-therapeutics-clarifies-fda-warning-202551368.html", "providerPublishTime": 1733430351, "type": "STORY", "relatedTickers": ["EWTX"]}, {"uuid": "e368ff10-9ae0-334d-915a-af6c147d0c2f", "title": "Truist Raises Price Target on Edgewise Therapeutics to $50 From $33, Keeps Buy Rating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/truist-raises-price-target-edgewise-123317712.html", "providerPublishTime": 1732710797, "type": "STORY", "relatedTickers": ["EWTX"]}, {"uuid": "e7c3aa6f-45a9-377e-9e53-ea9aeb645363", "title": "Edgewise Provides Statement Regarding Company\u2019s Relationship with Dr. Han Phan at Rare Disease Research", "publisher": "Business Wire", "link": "https://finance.yahoo.com/news/edgewise-provides-statement-regarding-company-193200877.html", "providerPublishTime": 1733427120, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/cTCB7B1GsIkoLWgtZsGp4Q--~B/aD0xODA4O3c9ODMzNDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/1932c32fc7393b9746384f37000797fd", "width": 8334, "height": 1808, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/5tfw_bpSpuQreCwFv5BIng--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/1932c32fc7393b9746384f37000797fd", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["EWTX"]}, {"uuid": "1c12f7a5-efbc-3237-83db-041ff50b86cc", "title": "Sector Update: Health Care", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-134217400.html", "providerPublishTime": 1734356537, "type": "STORY", "relatedTickers": ["EWTX"]}, {"uuid": "27286486-8587-3937-beb8-456c02e32555", "title": "Top Premarket Gainers", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-premarket-gainers-125357617.html", "providerPublishTime": 1734353637, "type": "STORY"}, {"uuid": "03c8e7a3-ae5c-3146-a5e5-52bf132843de", "title": "Sector Update: Health Care Stocks Mixed Pre-Bell Monday", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-mixed-141310400.html", "providerPublishTime": 1734358390, "type": "STORY", "relatedTickers": ["EWTX", "PRTC", "FHTX"]}]